Nuclear Imaging

Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.

Results show drug is effective and safe, leaves open question of optimal dosing

News | Cardiovascular Clinical Studies

Study Finds Olezarsen Cuts Triglyceride Levels by About Half

April 7, 2024 — An estimated 1 in 5 U.S. adults—and more than 2 in 5 adults aged 60 years and older—have elevated ...

April 07, 2024

CREDENCE and PACIFIC-1 study data demonstrate potential power of AI-QCT ISCHEMIA

News | Artificial Intelligence

Robust Diagnostic Accuracy and Prognostic Utility in Analyses from Large Scale Clinical Trials

March 28, 2024 — Cleerly, the company on a mission to create a new standard of care to aid in the diagnosis of heart ...

March 28, 2024

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

This patient milestone and the recent launch of Plaque Analysis and RoadMap Analysis further solidify HeartFlow as a pioneer in AI-enabled CAD diagnostics

News | FFR Technologies

HeartFlow Achieves Landmark Milestone of 250,000 Patients Assessed for Coronary Artery Disease (CAD) with FFRCT Analysis

January 3, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) precision coronary care ...

January 03, 2024

AI-powered NeuroShield automatically quantifies brain volumes using MRI data – the first of its kind with the capability to provide ethnicity-specific reference ranges

News | Artificial Intelligence

Heuron Showcasing Neuro AI Solutions and Presenting Abstract on AI Solutions for Stroke at RSNA23

November 21, 2023 — Heuron, a medical AI (artificial intelligence) imaging software solution company, under the ...

November 21, 2023

Technology-powered collaboration aims to deliver AI-enabled devices and digital solutions at the enterprise level to increase clinical and operational efficiencies, drive workflow enhancements and improve patient outcomes

News | Cardiovascular Business

GE HealthCare and University Hospitals Enter 10-Year Strategic Collaboration to Contemporize Its Imaging Fleet and Implement Enterprise Digital Solutions to Help Improve Patient Care and Optimize Processes

October 11, 2023 — Realizing a vision to deliver the best care to patients close to where they live in northern Ohio, GE ...

October 11, 2023

Offering healthcare facilities with the option to either use a flexible daily-leased rubidium program or build a full time PET program will ultimately increase access for suspected CAD patients to state of the art imaging with cardiac PET.

News | PET Imaging

Jubilant Radiopharma and Cardiac Imaging, Inc. Announce Exclusive Partnership to Expand Access for Mobile Cardiac PET Offering

October 5, 2023 — Jubilant DraxImage Inc., a wholly-owned subsidiary of Jubilant Pharma Limited, has entered into an ...

October 05, 2023

Study investigated impact of radiographic media contrast shortage on stroke patient scan data

News | Contrast Media

Researchers Discover Contrast Dye Shortage Affected Assessment of Stroke Patients

August 17, 2023 — University of Missouri School of Medicine neurologist Adnan Qureshi, MD recently led a study that ...

August 17, 2023

The medication, known as a “polypill,” includes three active ingredients (acetylsalicylic acid, ramipril, and atorvastatin)

News | Nuclear Imaging

World Health Organization Includes the Cardiovascular Polypill in its list of Essential Medicines after a Groundbreaking Study Led by the President of Mount Sinai Heart

August 3, 2023 — The cardiovascular polypill, developed by the Spanish National Centre for Cardiovascular Research (CNIC ...

August 03, 2023

A novel PET perfusion radiotracer, 18F-flurpiridaz, can diagnose coronary artery disease (CAD) in obese patients with a higher sensitivity and specificity compared to 99Tc-SPECT myocardial perfusion imaging (MPI)

News | SNMMI

Novel Radiotracer Demonstrates High Diagnostic Efficacy for Obese Patients with Coronary Artery Disease

June 28, 2023 — A novel PET perfusion radiotracer, 18F-flurpiridaz, can diagnose coronary artery disease (CAD) in obese ...

June 28, 2023

Jubilant DraxImage Inc., dba Jubilant Radiopharma, a wholly-owned subsidiary of Jubilant Pharma Limited, announced the clearance by the FDA to use its RUBY Rubidium Elution System and RUBY-FILL (Rubidium Rb82 generator) in mobile settings.

News | Cardiac Imaging

Jubilant Radiopharma Introduces RUBY Mobile Solutions

June 26, 2023 — Jubilant DraxImage Inc., dba Jubilant Radiopharma, a wholly-owned subsidiary of Jubilant Pharma Limited ...

June 26, 2023

Patients infected with beta and delta COVID-19 variants, and those who required hospital stays for COVID-19 infection, were more likely to experience heart issues associated with long COVID

News | Coronavirus (COVID-19)

New Analysis Shows COVID Variant and Severity of Illness Influence Cardiac Dysfunction, a Key Indicator of Long COVID

June 9, 2023 — Patients infected with beta and delta COVID-19 variants, and those who required hospital stays for COVID ...

June 09, 2023

The 2023 Multimodality Appropriate Use Criteria (AUC) for the Detection and Risk Assessment of Chronic Coronary Disease is now available online. The new document updates the 2013 AUC and includes several shifts in terminology.

News | SPECT Imaging

Societies Update Multimodality AUC: SPECT and PET Appropriate for Many Patients

June 5, 2023 — The 2023 Multimodality Appropriate Use Criteria (AUC) for the Detection and Risk Assessment of Chronic ...

June 05, 2023

A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population

News | Radiopharmaceuticals and Tracers

Daily Statin Reduces the Risk of Cardiovascular Disease in People Living with HIV, Large NIH Study Finds

April 13, 2023 — A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin ...

April 13, 2023

Researchers found evidence of heart muscle inflammation in a small number of patients with acute myocarditis after COVID-19 vaccination, but not in patients without acute myocarditis

News | Coronavirus (COVID-19)

Study Examines Heart Inflammation after COVID Vaccine

March 10, 2023 — Researchers found evidence of heart muscle inflammation in a small number of patients with acute ...

March 10, 2023